Free Newsletter
Contractor Positron opens radioactive-drug plant
Molecular imaging company Positron has opened a 10,000-square-foot cGMP-ready facility in Indiana for manufacturing both radioactive and non-radioactive pharma products and devices. The contract manufacturer, which specializes in nuclear cardiology, plans to focus initially on small batch, radioactive PET products. Positron release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: